SE464026B - Kristallint cefalexin-hydroklorid-monohydral, farmaceutiska kompositioner daerav, kristallina cefalexin-hydroklorid-alkanolsolvat - Google Patents

Kristallint cefalexin-hydroklorid-monohydral, farmaceutiska kompositioner daerav, kristallina cefalexin-hydroklorid-alkanolsolvat

Info

Publication number
SE464026B
SE464026B SE8405954A SE8405954A SE464026B SE 464026 B SE464026 B SE 464026B SE 8405954 A SE8405954 A SE 8405954A SE 8405954 A SE8405954 A SE 8405954A SE 464026 B SE464026 B SE 464026B
Authority
SE
Sweden
Prior art keywords
crystalline
cefalexin
hydrochloride
monohydrate
solvate
Prior art date
Application number
SE8405954A
Other languages
English (en)
Swedish (sv)
Other versions
SE8405954L (sv
SE8405954D0 (sv
Inventor
G L Engel
J M Indelicato
H A Rose
L J Mcshane
K S Yang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE8405954D0 publication Critical patent/SE8405954D0/xx
Publication of SE8405954L publication Critical patent/SE8405954L/
Publication of SE464026B publication Critical patent/SE464026B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8405954A 1983-12-01 1984-11-26 Kristallint cefalexin-hydroklorid-monohydral, farmaceutiska kompositioner daerav, kristallina cefalexin-hydroklorid-alkanolsolvat SE464026B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/556,887 US4600773A (en) 1983-12-01 1983-12-01 Crystalline cephalexin hydrochloride monohydrate

Publications (3)

Publication Number Publication Date
SE8405954D0 SE8405954D0 (sv) 1984-11-26
SE8405954L SE8405954L (sv) 1985-06-02
SE464026B true SE464026B (sv) 1991-02-25

Family

ID=24223233

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8405954A SE464026B (sv) 1983-12-01 1984-11-26 Kristallint cefalexin-hydroklorid-monohydral, farmaceutiska kompositioner daerav, kristallina cefalexin-hydroklorid-alkanolsolvat

Country Status (46)

Country Link
US (1) US4600773A (fr)
EP (1) EP0143658B1 (fr)
JP (1) JPS60132990A (fr)
KR (1) KR870000527B1 (fr)
AT (1) AT390616B (fr)
AU (1) AU566080B2 (fr)
BE (1) BE901142A (fr)
BG (1) BG40966A3 (fr)
BR (1) BR8406037A (fr)
CH (1) CH661732A5 (fr)
CS (1) CS248725B2 (fr)
CY (1) CY1505A (fr)
DD (1) DD229410A5 (fr)
DE (1) DE3443065A1 (fr)
DK (1) DK158354C (fr)
ES (1) ES538019A0 (fr)
FI (1) FI80274C (fr)
FR (1) FR2555990B1 (fr)
GB (1) GB2150566B (fr)
GR (1) GR81043B (fr)
GT (1) GT198400146A (fr)
HK (1) HK92089A (fr)
HU (1) HU192516B (fr)
IE (1) IE57886B1 (fr)
IL (1) IL73639A (fr)
IN (1) IN163078B (fr)
IT (1) IT1177329B (fr)
JO (1) JO1347B1 (fr)
LU (1) LU85650A1 (fr)
MA (1) MA20279A1 (fr)
MX (1) MX159670A (fr)
MY (1) MY102966A (fr)
NL (1) NL8403588A (fr)
NO (1) NO844711L (fr)
NZ (1) NZ210357A (fr)
OA (1) OA07876A (fr)
PH (1) PH20849A (fr)
PL (1) PL146014B1 (fr)
PT (1) PT79553B (fr)
SE (1) SE464026B (fr)
SG (1) SG59789G (fr)
SU (1) SU1251807A3 (fr)
YU (1) YU45680B (fr)
ZA (1) ZA849224B (fr)
ZM (1) ZM6384A1 (fr)
ZW (1) ZW19084A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2555989B1 (fr) * 1983-12-06 1987-02-20 Bristol Myers Sa Monohydrate de chlorocephadroxyle
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
DE150507T1 (de) * 1983-12-29 1987-02-26 Mochida Pharmaceutical Co., Ltd., Tokio/Tokyo Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4775751A (en) * 1985-06-03 1988-10-04 Eli Lilly & Company Process for cephalexin hydrochloride alcoholates
JPS63132893A (ja) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
US5721229A (en) * 1995-12-26 1998-02-24 Veterinary Pharmacy Corporation Soluble forms of cephalosporins and treatment of animals
GB9717629D0 (en) 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents
AT413282B (de) * 2002-02-01 2006-01-15 Sandoz Ag Kristalline salze der 7-(((5-amino-1,2,4-thiadiazol-3-yl) (fluoromethoxy-imino)acetyl)amino)-3- ((imino-1-piperazinylmethyl)
US20040033262A1 (en) * 2002-08-19 2004-02-19 Orchid Health Care Sustained release pharmaceutical composition of a cephalosporin antibiotic

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507861A (en) * 1966-09-14 1970-04-21 Lilly Co Eli Certain 3-methyl-cephalosporin compounds
US3655656A (en) * 1970-06-04 1972-04-11 Lilly Co Eli Crystalline cephalexin monohydrate
DE2317179C2 (de) * 1973-04-05 1982-11-25 Bristol-Myers Co., 10154 New York, N.Y. Verfahren zur Herstellung der relativ wasserunlöslichen kristallinen Form von Cefalexinmonohydrat
US3985747A (en) * 1974-05-24 1976-10-12 Bristol-Myers Company Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
JPS50151890A (fr) * 1974-05-30 1975-12-06
CH642850A5 (it) * 1978-10-20 1984-05-15 Ausonia Farma Srl Composizioni farmaceutiche ad attivita antibatterica contro infezioni da germi gram-positivi e gram-negativi.
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device

Also Published As

Publication number Publication date
SG59789G (en) 1989-12-29
JPH0548234B2 (fr) 1993-07-20
DD229410A5 (de) 1985-11-06
FI844631L (fi) 1985-06-02
IE843033L (en) 1985-06-01
DK158354B (da) 1990-05-07
IL73639A (en) 1988-06-30
FI844631A0 (fi) 1984-11-26
JO1347B1 (en) 1986-11-30
FI80274C (fi) 1990-05-10
HUT35685A (en) 1985-07-29
PH20849A (en) 1987-05-08
LU85650A1 (fr) 1985-07-17
SU1251807A3 (ru) 1986-08-15
NZ210357A (en) 1988-05-30
FR2555990B1 (fr) 1986-12-26
AT390616B (de) 1990-06-11
DE3443065A1 (de) 1985-06-20
GB2150566A (en) 1985-07-03
DK561284A (da) 1985-06-02
GB2150566B (en) 1987-08-26
JPS60132990A (ja) 1985-07-16
KR850004765A (ko) 1985-07-27
IT8423746A0 (it) 1984-11-27
ATA373284A (de) 1989-11-15
GR81043B (en) 1985-03-27
IE57886B1 (en) 1993-05-05
FR2555990A1 (fr) 1985-06-07
AU566080B2 (en) 1987-10-08
FI80274B (fi) 1990-01-31
BE901142A (fr) 1985-05-28
KR870000527B1 (ko) 1987-03-14
IT1177329B (it) 1987-08-26
PL250593A1 (en) 1985-07-30
MA20279A1 (fr) 1985-07-01
ZW19084A1 (en) 1985-06-12
NL8403588A (nl) 1985-07-01
EP0143658A2 (fr) 1985-06-05
CH661732A5 (de) 1987-08-14
NO844711L (no) 1985-06-03
MX159670A (es) 1989-08-02
DE3443065C2 (fr) 1989-03-23
SE8405954L (sv) 1985-06-02
DK561284D0 (da) 1984-11-27
PT79553A (en) 1984-12-01
CS248725B2 (en) 1987-02-12
EP0143658B1 (fr) 1989-03-22
DK158354C (da) 1990-10-01
GT198400146A (es) 1986-05-20
IT8423746A1 (it) 1986-05-27
HK92089A (en) 1989-11-24
YU199684A (en) 1987-02-28
IN163078B (fr) 1988-08-06
PT79553B (en) 1986-12-15
ZM6384A1 (en) 1985-07-22
YU45680B (sh) 1992-07-20
ES8602011A1 (es) 1985-11-01
SE8405954D0 (sv) 1984-11-26
IL73639A0 (en) 1985-02-28
GB8430073D0 (en) 1985-01-09
CY1505A (en) 1990-08-03
AU3589784A (en) 1985-06-06
MY102966A (en) 1993-03-31
ZA849224B (en) 1986-07-30
PL146014B1 (en) 1988-12-31
HU192516B (en) 1987-06-29
BR8406037A (pt) 1985-08-27
BG40966A3 (en) 1987-03-14
OA07876A (fr) 1986-11-20
EP0143658A3 (en) 1986-02-12
ES538019A0 (es) 1985-11-01
US4600773A (en) 1986-07-15

Similar Documents

Publication Publication Date Title
JPS62174018A (ja) 細菌性感染症治療剤
SE464026B (sv) Kristallint cefalexin-hydroklorid-monohydral, farmaceutiska kompositioner daerav, kristallina cefalexin-hydroklorid-alkanolsolvat
US4775751A (en) Process for cephalexin hydrochloride alcoholates
DE1795188C3 (de) 3-Alkoxymethylcephalosporine, Verfahren zu deren Herstellung und die diese enthaltenden pharmazeutischen Zusammensetzungen
HU181497B (en) Process for preparing crystalline sodium salt of oximino-7-amino-thiazolyl-acetamido-3-acetoxymethyl-cef-3-em-4-carboxylic acid
SU1151213A3 (ru) Способ получени цефалоспоринов или их солей
DE2222434C2 (de) Cephalosporin-Derivat und Verfahren zu dessen Herstellung
JP4000397B2 (ja) モルヒネ−６−グルクロニドの新しい結晶形熊
WO2007062335A2 (fr) Nouveau derive de la pleuromutiline et son utilisation
US3985747A (en) Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
JP2723088B2 (ja) セファロスポリン化合物の新規な結晶
SK143697A3 (en) A process for preparing form 1 ranitidine hydrochloride
JPH05508170A (ja) 新規なジフルオロキノロンと、その合成方法と、それを含む医薬
HU189712B (en) Process for preparing new cef-3-em-carboxylic acid derivatives with antibiotic activity
US4959469A (en) Crystalline cephalosporin compounds
US4474780A (en) Crystalline cephalosporin
KR0177844B1 (ko) 항균성 페넴화합물
GB2052483A (en) Crystalline cephalosporin salts
DE3788279T2 (de) Kristalline cephalosporinzusammensetzungen, verfahren und zwischenprodukte für ihre herstellung.
US20240277677A1 (en) Salt form and crystal form thereof of sulfonylurea ring substituted compound
US5068322A (en) Crystalline cephalosporin compounds
CA1234799A (fr) Derives de cephalosporine
EP0548018A1 (fr) Imidazoles
JPH10152491A (ja) 結晶性カルバペネム化合物
JPH03206038A (ja) 抗菌剤

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8405954-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8405954-2

Format of ref document f/p: F